Article
Bcr-Abl-mediated molecular mechanism for apoptotic suppression in multipotent haemopoietic cells: a role for PKCbetaII.
Cellular signalling - 1 Feb 2004
Xenaki Dia, Pierce Andrew, Underhill-Day Nick, Whetton Anthony D, Owen-Lynch P Jane
Abstract excerpt
Bcr-Abl protein tyrosine kinase (PTK) activity is a feature of chronic myeloid leukaemia and confers a survival advantage on haemopoietic progenitor cells. We have expressed conditional mutant of the Bcr-Abl PTK in the FDCP-Mix A4 multipotent haematopoietic cell line in order to examine the molec...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
